Search Results - "Yamashita, Kumiko"

Protective effect of sodium–glucose cotransporter 2 inhibitors in patients with rapid renal function decline, stage G3 or G4 chronic kidney disease and type 2 diabetes by Miyoshi, Hideaki, Kameda, Hiraku, Yamashita, Kumiko, Nakamura, Akinobu, Kurihara, Yoshio

“…Aims/Introduction The risk of end‐stage kidney disease increases in proportion to the decline in the estimated glomerular filtration rate (eGFR). Although…”
Get full text

Do the benefits of sodium-glucose cotransporter 2 inhibitors exceed the risks in patients with type 1 diabetes? by Kamoshima, Hikaru, Nomoto, Hiroshi, Yamashita, Kumiko, Takahashi, Yuka, Tsuchida, Kazuhisa, Kuwabara, Saki, Miya, Aika, Cho, Kyu Yong, Kameda, Hiraku, Nakamura, Akinobu, Atsumi, Tatsuya, Taneda, Shinji, Kurihara, Yoshio, Aoki, Shin, Ono, Yuri, Miyoshi, Hideaki

“…Sodium-glucose cotransporter 2 inhibitors (SGLT2is) are well-established means of improving glycemia and preventing cardio-renal events in patients with type 2…”
Get full text

Impact of sodium-glucose cotransporter 2 inhibitors on renal function in participants with type 2 diabetes and chronic kidney disease with normoalbuminuria by Nakamura, Akinobu, Miyoshi, Hideaki, Kameda, Hiraku, Yamashita, Kumiko, Kurihara, Yoshio

“…We compared the effects of sodium-glucose cotransporter 2 (SGLT2) inhibitors on renal function in participants with type 2 diabetes and chronic kidney disease…”
Get full text

Sodium–glucose cotransporter 2 inhibitors reduce day‐to‐day glucose variability in patients with type 1 diabetes by Chiba, Koki, Nomoto, Hiroshi, Nakamura, Akinobu, Cho, Kyu Yong, Yamashita, Kumiko, Shibayama, Yui, Miya, Aika, Kameda, Hiraku, Kurihara, Yoshio, Aoki, Shin, Atsumi, Tatsuya, Miyoshi, Hideaki

“…Aims/Introduction Sodium–glucose cotransporter 2 inhibitors (SGLT2i) are used worldwide because of their multiple benefits for patients with type 2 diabetes…”
Get full text

Attenuated Total Reflection Spectroscopy in Time Domain Using Terahertz Coherent Pulses by Hirori, Hideki, Yamashita, Kumiko, Nagai, Masaya, Tanaka, Koichiro

Get full text

Effects of pemafibrate on lipid metabolism in patients with type 2 diabetes and hypertriglyceridemia: A multi-center prospective observational study, the PARM-T2D study by Kito, Kenichi, Nomoto, Hiroshi, Sakuma, Ichiro, Nakamura, Akinobu, Cho, Kyu Yong, Kameda, Hiraku, Miya, Aika, Omori, Kazuno, Yanagiya, Shingo, Handa, Takahisa, Taneda, Shinji, Takeuchi, Jun, Nagai, So, Yamashita, Kumiko, Kurihara, Yoshio, Atsumi, Tatsuya, Miyoshi, Hideaki

“…•This prospective study investigated pemafibrate for patients with type 2 diabetes.•Pemafibrate reduced triglycerides and increased high-density…”
Get full text

Do the benefits of sodium-glucose cotransporter 2 inhibitors exceed the risks in patients with type 1 diabetes? by Kamoshima, Hikaru, Nomoto, Hiroshi, Yamashita, Kumiko, Takahashi, Yuka, Tsuchida, Kazuhisa, Kuwabara, Saki, Miya, Aika, Cho, Kyu Yong, Kameda, Hiraku, Nakamura, Akinobu, Atsumi, Tatsuya, Taneda, Shinji, Kurihara, Yoshio, Aoki, Shin, Ono, Yuri, Miyoshi, Hideaki

“…Sodium-glucose cotransporter 2 inhibitors (SGLT2is) are well-established means of improving glycemia and preventing cardio-renal events in patients with type 2…”
Get full text

A novel genetic syndrome with STARD9 mutation and abnormal spindle morphology by Okamoto, Nobuhiko, Tsuchiya, Yuki, Miya, Fuyuki, Tsunoda, Tatsuhiko, Yamashita, Kumiko, Boroevich, Keith A., Kato, Mitsuhiro, Saitoh, Shinji, Yamasaki, Mami, Kanemura, Yonehiro, Kosaki, Kenjiro, Kitagawa, Daiju

“…Intellectual disability (ID) is one of neurodevelopmental disorders characterized by serious defects in both intelligence and adaptive behavior. Although it…”
Get full text

Production and Physicochemical Properties of Water-Insoluble Glucan from Streptococcus mutans by MASUMOTO, KEN, YAMASHITA, KUMIKO, YOSHIDA, AKIYOSHI, HAYASHI, SHIN'ICHI, MACHIDA, YOSHIHARU, NAGAI, TSUNEJI

“…A method for the production of water-insoluble glucan was developed by utilizing the extracellular glucosyltransferase present in the culture fluid of…”
Get full text

Metabolic Fate of Clonidine (IV)：Plasma Protein Binding of Clonidine In vitro and In vivo and Transfer to Fetus and Milk in Rats after Subcutaneous Administration of Clonidine by YAMAHATA, Tohru, MINAKI, Yasuo, NISHIKAWA, Hitoshi, ESUMI, Yoshio, JIN, Yoshitaka, TAKAO, Atsushi, MASHIKO, Toshiyuki, ICHIGE, Kazumi, YAMASHITA, Kumiko, OHTSUBO, Miwa, HORI, Katsuyuki

“…The plasma protein binding of 14C-clonidine in vitro and in vivo and its transfer into the fetus and milk in rats were investigated. 1. The binding ratios of…”
Get full text

Metabolic Fate of Clonidine (I)：Absorption, Distribution and Excretion in Rats, Dogs and Monkeys after Subcutaneous Administration of Clonidine by YAMAHATA, Tohru, MINAKI, Yasuo, NISHIKAWA, Hitoshi, ESUMI, Yoshio, JIN, Yoshitaka, TAKAO, Atsushi, MASHIKO, Toshiyuki, ICHIGE, Kazumi, YAMASHITA, Kumiko, OHTSUBO, Miwa, HORI, Katsuyuki

“…After a single subcutaneous administration of 14C-clonidine at a dose of 1 mg/kg (principally) to rats, dogs and a monkey, the absorption, distribution and…”
Get full text

Studies on the Metabolic Fate of Angiotensin II. (III). Distribution, Excretion and Metabolism of Angiotensin II in Rat by NAGAI, Akihiko, CHIDA, Satoshi, HORI, Katsuyuki, YAMASHITA, Kumiko, JIN, Yoshitaka, ESUMI, Yoshio

Get full text

Accurate measurement of phase shift on the surface-plasmon resonance by Yoshida, Makoto, Ohtake, Hideyuki, Tanaka, Koichiro, Yamashita, Kumiko, Hirori, Hideki

“…We have developed time-domain attenuated-total-reflection spectroscopy using terahertz pulses (THz-TD-ATR). Accuracy in the time-domain measurements enables us…”
Get full text

Dynamics of biomolecules in water by terahertz time-domain attenuated total reflection spectroscopy by Arikawa, T., Yamashita, K., Hirori, H., Nagai, M., Tanaka, K.

“…We measure optical constants of biomolecular solution in THz region with time-domain attenuated total reflection technique, which is the most sensitive method…”
Get full text